Hormone News and Research

RSS

A hormone is a chemical released by one or more cells that affects cells in other parts of the organism. Only a small amount of hormone is required to alter cell metabolism. It is essentially a chemical messenger that transports a signal from one cell to another.

Suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer

A modest suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer, researchers from Wake Forest University School of Medicine and other centers reported today at ENDO 2005, the annual meeting of the Endocrine Society, in San Diego.

5 Jun 2005

Toxic chemicals that poisoned your great-grandparents may also damage your health

New U.S. research is suggesting that chemicals can change the way genes work and that toxic chemicals that poisoned your great-grandparents may also damage your health.

5 Jun 2005

Gene research may help explain how adorable children become surly teenagers

University of Utah researchers showed that a fruit fly gene is crucial for determining when juveniles begin to mature into adults, and how the transformation initially proceeds. Understanding this process in humans may help explain how adorable children become surly teenagers.

3 Jun 2005

Role of toxins in inherited disease

A disease you are suffering today could be a result of your great-grandmother being exposed to an environmental toxin during pregnancy.

3 Jun 2005

Alarming trends among steroid users

Major findings in a new survey of 500 steroid users reveal specific, alarming trends: most are non-athletes whose sole intention is to improve their physical appearance; users are taking larger doses than previously recorded; and even though nearly all admitted to adverse side effects, health concerns are not enough to deter their steroid use.

2 Jun 2005

Study links TNF to androgen deficiency in rheumatoid arthritis patients and suggest a novel pathway in inflammation

A protein involved in multiple cell functions, tumor necrosis factor (TNF) is perhaps best known for provoking destructive inflammation. Recently, drugs blocking the action of TNF have shown promise in the early treatment of rheumatoid arthritis (RA).

2 Jun 2005

Harmful chemicals may reprogram gene response to estrogen

New research shows that exposure to harmful chemicals and drugs during critical developmental periods early in life may actually "reprogram" the way certain genes respond to the female hormone estrogen. This genetic reprogramming may determine whether people with a genetic predisposition for a disease actually develop the disease.

1 Jun 2005

Scientists bridge major gap in prostate cancer research

Everyman scientists at The Institute of Cancer Research have established an initiative to promote vital research for the development and clinical testing of new drugs for the treatment of prostate cancer. This announcement coincides with the launch of The Institute's Everyman Male Cancer Awareness Month which runs throughout June.

1 Jun 2005

Having twins reduces the risk of many types of women's cancer

...and starting a family later in life increases risk of breast cancer and melanoma but reduces the risk of ovarian, cervix and uterine cancer according to an international study conducted by a team from The Queensland Institute of Medical Research (QIMR).

1 Jun 2005

New Calcitonin drug delivery research holds promise for osteoporosis sufferers

Calcitonin, a hormone that lowers calcium levels in the blood and prevents bone loss, has only been available in an injectable and nasally-administered format to date.

1 Jun 2005

New study linking pain relievers and breast cancer fails to convince experts

Research in recent years has consistently linked the use of aspirin and other anti-inflammatory pain relievers with a lower risk of colon cancer, but findings about the drugs' effect on breast-cancer risk have been very mixed with some studies suggesting that the pain relievers protect against breast cancer, while others have found no link.

1 Jun 2005

Diabetics more sensitive to cardiovascular effects from air pollution

People with diabetes may be at higher risk for cardiovascular problems when air pollution levels are higher, according to a new study of Boston-area residents. The ability of the blood vessels to control blood flow was impaired in adults with diabetes on days with elevated levels of particles from traffic and coal-burning power plants.

31 May 2005

Environment factors can interact with genetics to increase disease risk

31 May 2005

Nastech Pharmaceutical awarded new breast cancer patent

Nastech Pharmaceutical Company today announced that it has been awarded U.S. patent No. 6,894,026, entitled, "Long-acting Oxytocin Analogues for the Treatment and Prevention of Breast Cancer and Psychiatric Disorders."

31 May 2005

Pregnant women's exposure to phthalates has adverse effects on genital development in their male children

For the first time, researchers have identified an association between pregnant women’s exposure to a nearly ubiquitous class of chemicals known as phthalates and adverse effects on genital development in their male children.

30 May 2005

Exposure to pharmaceutical estrogen during fetal development can permanently "reprogram" tissue in a way that determines whether tumors will develop in adulthood

Researchers at The University of Texas M. D. Anderson Cancer Center may have uncovered the reason why some people who are genetically predisposed to hormone-dependent cancers develop the disease as an adult, while others who are similarly susceptible don't.

30 May 2005

Chemicals in food packaging linked to breast cancer

Chemicals found in some food packaging materials have been shown in a new study to affect the development of breast tissue in mice, which suggests, say scientists, that women exposed to such chemicals, which mimic female hormones, may be at increased risk of breast cancer.

30 May 2005

Bioniche Life Sciences granted European patent

Bioniche Life Sciences has announced that it has had another patent granted on its core technology: Mycobacterial Cell Wall-DNA Complex (MCC). The European Patent Organization (EPO) granted the patent: - "Composition and Method for Inducing Apoptosis in Prostate Cancer Cells" (EPO1165106)

30 May 2005

A new technique might allow women diagnosed with cancer the opportunity to have children when chemotherapy and radiation treatments rob them of their fertility

Freezing eggs is one thing; thawing them safely so they can lead to pregnancy is the challenge. In the past, efforts to freeze a woman's eggs, or oocytes, have not worked well because the cells are large. When the egg is thawed, ice crystals cause damage that prevents the egg from being fertilized.

29 May 2005